277 related articles for article (PubMed ID: 19570828)
1. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
Brereton CF; Sutton CE; Lalor SJ; Lavelle EC; Mills KH
J Immunol; 2009 Aug; 183(3):1715-23. PubMed ID: 19570828
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
[TBL] [Abstract][Full Text] [Related]
3. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses.
Walsh KP; Brady MT; Finlay CM; Boon L; Mills KH
J Immunol; 2009 Aug; 183(3):1577-86. PubMed ID: 19587018
[TBL] [Abstract][Full Text] [Related]
4. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
Hickey FB; Brereton CF; Mills KH
J Leukoc Biol; 2008 Jul; 84(1):234-43. PubMed ID: 18401006
[TBL] [Abstract][Full Text] [Related]
5. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
Sutton C; Brereton C; Keogh B; Mills KH; Lavelle EC
J Exp Med; 2006 Jul; 203(7):1685-91. PubMed ID: 16818675
[TBL] [Abstract][Full Text] [Related]
6. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
7. Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
Lalor SJ; Dungan LS; Sutton CE; Basdeo SA; Fletcher JM; Mills KH
J Immunol; 2011 May; 186(10):5738-48. PubMed ID: 21471445
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
9. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23.
Aliahmadi E; Gramlich R; Grützkau A; Hitzler M; Krüger M; Baumgrass R; Schreiner M; Wittig B; Wanner R; Peiser M
Eur J Immunol; 2009 May; 39(5):1221-30. PubMed ID: 19350551
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
12. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer.
Miyahara Y; Odunsi K; Chen W; Peng G; Matsuzaki J; Wang RF
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15505-10. PubMed ID: 18832156
[TBL] [Abstract][Full Text] [Related]
13. IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid.
Yabu M; Shime H; Hara H; Saito T; Matsumoto M; Seya T; Akazawa T; Inoue N
Int Immunol; 2011 Jan; 23(1):29-41. PubMed ID: 21131367
[TBL] [Abstract][Full Text] [Related]
14. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
Gyülvészi G; Haak S; Becher B
Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
[TBL] [Abstract][Full Text] [Related]
15. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
[TBL] [Abstract][Full Text] [Related]
16. Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis.
Zhang X; Markovic-Plese S
Clin Neurol Neurosurg; 2010 Sep; 112(7):641-5. PubMed ID: 20570038
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.
Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M
J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432
[TBL] [Abstract][Full Text] [Related]
18. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
[TBL] [Abstract][Full Text] [Related]
19. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
